ClinicalTrials.gov
public full text
Public Domain
Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals
Currently, the efficacy of COVID-19 vaccination in immunodeficient patients is unknown. Here the investigators aim to evaluate the efficacy of COVID-19 vaccines in immunodeficient patients compared to healthy controls. The investigators will assess the humoral and cellular response to COVID-19 vaccination in these subjects in detail. Furthermore, factors associated with good response to vaccination will be identified. The results of this study will help to guide future recommendations on COVID-19 vaccination in this population.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC)#1096549
- COVID-19 Vaccination of Immunodeficient Persons (COVAXID)#1128039
- Determinants of COVID-19 and non-COVID-19 vaccine confidence in lowand middle-income countries: A systematic review of qualitative evidence and thematic synthesis#443474
- Mast Cells in Acute COVID ‐19 Patients#145038
- Th1 Response to Influenza: Aging and Vaccine Efficacy#805773
Record · ID 873616
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive